Angioedemas, Hereditary

• 

  Subject Areas on Research

  • Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden. 
  • Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. 
  • Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. 
  • Guidelines for management of hereditary angioedema: What is new? What is missing? 
  • Hereditary angioedema: current and emerging treatment options. 
  • Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study. 
  • Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape. 
  • Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. 
  • Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study. 
  • Patient perspectives on the treatment burden of injectable medication for hereditary angioedema. 
  • Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs. 
  • The 2011 ACR meeting: what's new in the Windy City. 
  • The Contact Activation System: Problems and Paradoxes for Cardiac Anesthesiologists.